| The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies JM Kim, JA Miller, R Kotecha, R Xiao, A Juloori, MC Ward, MS Ahluwalia, ... Journal of neuro-oncology 133, 357-368, 2017 | 122 | 2017 |
| The impact of sequencing PD-1/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasis R Kotecha, JM Kim, JA Miller, A Juloori, ST Chao, ES Murphy, ... Neuro-oncology 21 (8), 1060-1068, 2019 | 99 | 2019 |
| A phase 1 trial of concurrent or sequential ipilimumab, nivolumab, and stereotactic body radiotherapy in patients with stage IV NSCLC study CM Bestvina, KB Pointer, T Karrison, H Al-Hallaq, PC Hoffman, MJ Jelinek, ... Journal of Thoracic Oncology 17 (1), 130-140, 2022 | 71 | 2022 |
| Influence of preoperative radiation field on postoperative leak rates in esophageal cancer patients after trimodality therapy A Juloori, SL Tucker, R Komaki, Z Liao, AM Correa, SG Swisher, ... Journal of Thoracic Oncology 9 (4), 534-540, 2014 | 69 | 2014 |
| CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer SI Gutiontov, WT Turchan, LF Spurr, SJ Rouhani, CS Chervin, ... Scientific reports 11 (1), 20059, 2021 | 63 | 2021 |
| American Brachytherapy Society consensus statement for soft tissue sarcoma brachytherapy AO Naghavi, DC Fernandez, N Mesko, A Juloori, A Martinez, JG Scott, ... Brachytherapy 16 (3), 466-489, 2017 | 63 | 2017 |
| Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases S Parsai, JA Miller, A Juloori, ST Chao, R Kotecha, AM Mohammadi, ... Journal of Neurosurgery 132 (2), 503-511, 2019 | 57 | 2019 |
| Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases A Juloori, JA Miller, S Parsai, R Kotecha, MS Ahluwalia, AM Mohammadi, ... Journal of neurosurgery 132 (1), 188-196, 2019 | 50 | 2019 |
| Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer SM Shirvani, A Juloori, PK Allen, R Komaki, Z Liao, D Gomez, M O'Reilly, ... International Journal of Radiation Oncology* Biology* Physics 87 (1), 139-147, 2013 | 49 | 2013 |
| The oligometastatic spectrum in the era of improved detection and modern systemic therapy RR Katipally, SP Pitroda, A Juloori, SJ Chmura, RR Weichselbaum Nature Reviews Clinical Oncology 19 (9), 585-599, 2022 | 46 | 2022 |
| Phase 1 randomized trial of stereotactic body radiation therapy followed by nivolumab plus ipilimumab or nivolumab alone in advanced/unresectable hepatocellular carcinoma A Juloori, RR Katipally, JM Lemons, AK Singh, R Iyer, JR Robbins, ... International Journal of Radiation Oncology* Biology* Physics 115 (1), 202-213, 2023 | 37 | 2023 |
| A 2D nanoradiosensitizer enhances radiotherapy and delivers STING agonists to potentiate cancer immunotherapy T Luo, GT Nash, X Jiang, X Feng, J Mao, J Liu, A Juloori, AT Pearson, ... Advanced Materials 34 (39), 2110588, 2022 | 34 | 2022 |
| Long-term outcomes after autologous or tissue expander/implant–based breast reconstruction and postmastectomy radiation for breast cancer BV Manyam, C Shah, NM Woody, CA Reddy, MA Weller, A Juloori, ... Practical Radiation Oncology 9 (6), e497-e505, 2019 | 30 | 2019 |
| Evolving paradigm of radiotherapy for high‐risk prostate cancer: current consensus and continuing controversies A Juloori, C Shah, K Stephans, A Vassil, R Tendulkar Prostate Cancer 2016 (1), 2420786, 2016 | 27 | 2016 |
| Incidence and predictors of severe acute esophagitis and subsequent esophageal stricture in patients treated with accelerated hyperfractionated chemoradiation for limited-stage … JD Grant, SM Shirvani, C Tang, A Juloori, NC Rebueno, PK Allen, ... Practical radiation oncology 5 (4), e383-e391, 2015 | 27 | 2015 |
| Nivolumab, nabpaclitaxel, and carboplatin followed by risk/response adaptive de-escalated locoregional therapy for HPV-associated oropharyngeal cancer: OPTIMA II trial. A Rosenberg, N Agrawal, AT Pearson, TY Seiwert, Z Gooi, EA Blair, ... Journal of Clinical Oncology 39 (15_suppl), 6011-6011, 2021 | 23 | 2021 |
| Effect of switching systemic treatment after stereotactic radiosurgery for oligoprogressive, metastatic renal cell carcinoma PC Barata, P Mendiratta, R Kotecha, D Gopalakrishnan, A Juloori, ... Clinical Genitourinary Cancer 16 (5), 413-419. e1, 2018 | 22 | 2018 |
| Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience AJ Rosenberg, N Agrawal, A Pearson, Z Gooi, E Blair, J Cursio, A Juloori, ... Oral oncology 122, 105566, 2021 | 20 | 2021 |
| Definitive chemoradiation in locally advanced squamous cell carcinoma of the hypopharynx: long-term outcomes and toxicity A Juloori, SA Koyfman, JL Geiger, NP Joshi, NM Woody, BB Burkey, ... Anticancer Research 38 (6), 3543-3549, 2018 | 20 | 2018 |
| Long‐term complications and reconstruction failures in previously radiated breast cancer patients receiving salvage mastectomy with autologous reconstruction or tissue expander … BV Manyam, C Shah, NM Woody, CA Reddy, MA Weller, A Juloori, ... The Breast Journal 25 (6), 1071-1078, 2019 | 18 | 2019 |
